Which has the lower trailing P/E, DXCM or MTD?

MTD has the lower trailing P/E: DXCM trades at 34.52 and MTD at 30.99. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DXCM or MTD?

Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus MTD at 3.54%.

Is DXCM or MTD more profitable?

MTD runs the higher net margin — DXCM at 20.12% versus MTD at 21.91%.

How have DXCM and MTD total returns compared?

Over the past 10 years, DXCM delivered 13.57% and MTD delivered 12.77% annualized total return. Past performance doesn't predict future results.

DexCom, Inc. (DXCM) vs Mettler-Toledo International Inc. (MTD)

A side-by-side comparison of DexCom, Inc. and Mettler-Toledo International Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

DXCM

DexCom, Inc.

$32.96B

$87.34HealthcareDelayed quote: Sep 16, 2026, 4:00 PM EDT

MTD

Mettler-Toledo International Inc.

$27.86B

$1,378.71HealthcareDelayed quote: Sep 16, 2026, 3:59 PM EDT

Total return — DXCM vs MTD

growth of $100 · dividends reinvested · last 10y

DXCM +261.5% (+13.7%/yr)MTD +227.8% (+12.6%/yr)DXCM compounded faster over this window

DXCM MTD

DXCM vs MTD: by the numbers

•DXCM is the larger company ($32.96B vs $27.86B market cap).
•MTD trades at the lower trailing earnings multiple (30.99 vs 34.52 P/E), one valuation lens rather than an overall verdict.
•MTD converts more revenue to profit (21.91% vs 20.12% net margin).
•DXCM grew revenue faster over the past five years (18.03% vs 3.54% CAGR).

Metrics side by side

Valuation

Metric	DXCM	MTD
P/E ratio	34.52	30.99
Forward P/E	32.74	29.13
P/S ratio	6.63	6.74
P/B ratio	12.57	2172.69
EV / EBITDA	23.70	22.72
FCF yield	4.26%	3.10%

Profitability

Metric	DXCM	MTD
Gross margin	62.47%	59.30%
Operating margin	22.92%	28.69%
Net margin	20.12%	21.91%
ROE	38.14%	7062.40%
ROIC	21.71%	38.57%

Growth (annualized)

Metric	DXCM	MTD
Revenue CAGR (5Y)	18.03%	3.54%
EPS CAGR (5Y)	10.31%	10.81%
FCF CAGR (5Y)	69.49%	2.13%
Total return CAGR (5Y)	-9.57%	-4.09%

Frequently asked

Which has the lower trailing P/E, DXCM or MTD?: MTD has the lower trailing P/E: DXCM trades at 34.52 and MTD at 30.99. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DXCM or MTD?: Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus MTD at 3.54%.
Is DXCM or MTD more profitable?: MTD runs the higher net margin — DXCM at 20.12% versus MTD at 21.91%.
How have DXCM and MTD total returns compared?: Over the past 10 years, DXCM delivered 13.57% and MTD delivered 12.77% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DXCM analysis Full MTD analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio Mettler-Toledo International P/E ratio DexCom ROE Mettler-Toledo International ROE DexCom operating margin Mettler-Toledo International operating margin DexCom revenue growth Mettler-Toledo International revenue growth DexCom free cash flow Mettler-Toledo International free cash flow

DexCom & Mettler-Toledo International appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.